StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
12
Publishing Date
2022 - 12 - 12
1
2022 - 06 - 02
1
2022 - 02 - 24
1
2022 - 01 - 19
1
2022 - 01 - 18
1
2021 - 11 - 12
1
2021 - 10 - 18
1
2021 - 10 - 15
1
2021 - 07 - 15
1
2021 - 06 - 25
1
2021 - 04 - 27
1
2021 - 04 - 21
1
Sector
Health technology
12
Tags
Alcohol use disorder
3
Alzheimer’s
5
Application
12
Approval
13
Biotech
7
Biotech-bay
7
Cancer
10
Chronic hepatitis b
4
Clinical-trials-phase-i
6
Clinical-trials-phase-ii
4
Clinical-trials-phase-iii
14
Collaboration
4
Conference
19
Day
5
Disease
13
Drug
11
Earnings
21
Europe
5
Events
26
Fda
9
Financial
21
Financial results
13
Food
5
Genetown
37
Global
4
Growth
5
Hepatitis
19
Hypertension
5
Iot
7
Kidney
4
Leo
4
Liver
16
Market
10
Media
4
Meeting
6
N/a
80
New drug
4
Ongoing
5
People
9
Pharma
4
Pharmaceuticals
6
Phase 1
7
Phase 2
11
Phase 3
23
Positive
19
Potential
4
Presentation
12
Program
6
Report
10
Research
19
Results
79
Study
12
Technology
12
Therapeutics
9
Topline
7
Treatment
38
Trial
12
Update
6
Vir-2218
4
Year
7
Entities
Alnylam pharmaceuticals, inc.
12
Gilead sciences, inc.
2
Phio pharmaceuticals corp.
1
Sanofi
2
Silence therapeutics plc
1
Stoke therapeutics, inc.
1
Takeda pharmaceutical company limited
1
Thermo fisher scientific inc
1
Vbi vaccines, inc.
1
Vir biotechnology, inc.
6
Symbols
AAPL
51
ABB
28
ABLZF
26
ABT
34
ACN
41
AIHS
33
ALGN
35
ARVL
86
ASX
54
AVGO
25
BDX
29
CRS
46
DELL
27
DHR
33
DXC
27
EDU
24
ERIC
63
F
23
FNCTF
86
GE
25
GOOG
32
GOOGL
32
GRRR
37
GSIT
28
GSK
23
HON
45
IBM
27
IFNNF
24
IGT
48
INTC
44
JNJ
45
KBR
29
KULR
46
LLY
27
LUMN
33
MCHP
65
MIND
42
MS
87
MSFT
47
MU
26
NAAS
53
NIPNF
24
ORCL
27
PHG
26
ROP
25
RXT
194
SAP
39
SAPGF
34
SNEJF
26
SNY
68
SNYNF
39
STG
33
SUAC
24
TMO
60
VIOT
29
VIR
27
VSH
43
WKEY
26
XELA
28
YQ
33
Exchanges
Nasdaq
12
Nyse
2
Crawled Date
2022 - 12 - 12
1
2022 - 06 - 02
1
2022 - 02 - 25
1
2022 - 01 - 19
1
2022 - 01 - 18
1
2021 - 11 - 12
1
2021 - 10 - 18
1
2021 - 10 - 15
1
2021 - 07 - 15
1
2021 - 06 - 25
1
2021 - 04 - 27
1
2021 - 04 - 21
1
Crawled Time
01:00
1
12:00
1
13:00
2
13:15
1
14:00
2
15:00
1
16:00
1
18:00
1
19:00
1
22:00
1
Source
www.biospace.com
8
www.globenewswire.com
2
www.prnewswire.com
1
www.vbivaccines.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Technology
symbols :
ALNY
save search
RNAi Technology Global Market to Reach $3.5 Billion by 2028 at a CAGR of 10.1%
Published:
2022-12-12
(Crawled : 22:00)
- prnewswire.com
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-3.59%
|
O:
2.32%
H:
0.0%
C:
0.0%
SLN
|
$22.75
3.32%
3.21%
310K
|
Health Technology
|
47.97%
|
O:
1.63%
H:
13.76%
C:
-6.11%
PHIO
|
$0.631
-1.07%
-1.08%
29K
|
Health Technology
|
-86.99%
|
O:
-4.12%
H:
6.87%
C:
1.78%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-38.77%
|
O:
1.46%
H:
0.99%
C:
-0.97%
global
technology
market
Alnylam Announces Publication of Preclinical Results Based on Novel Conjugate Technology That Facilitates Delivery of Short Interfering RNA to the Central Nervous System and Other Extrahepatic Tissues
Published:
2022-06-02
(Crawled : 16:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.47%
|
O:
-2.55%
H:
0.0%
C:
-0.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.81%
|
O:
-0.13%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
17.36%
|
O:
-0.4%
H:
2.47%
C:
2.4%
system
preclinical
technology
results
publication
pre-clinical
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published:
2022-02-24
(Crawled : 01:00)
- biospace.com/
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-71.4%
|
O:
-6.87%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
8.82%
|
O:
-1.04%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-2.07%
|
O:
-2.95%
H:
0.0%
C:
0.0%
financial results
technology
report
results
biotech
iot
Ceptur Therapeutics Launches with $75M Series A Financing to Advance RNA Therapeutics Based on Proprietary U1 Adaptor Technology
Published:
2022-01-19
(Crawled : 13:00)
- biospace.com/
STOK
|
$12.08
3.69%
3.56%
1M
|
Health Technology
|
-38.28%
|
O:
-1.31%
H:
2.13%
C:
-3.48%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.86%
|
O:
-1.41%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-0.76%
|
O:
-2.91%
H:
2.06%
C:
-1.88%
technology
therapeutics
n-Lorem Foundation Partners with Alnylam to Expand Technology Access to RNAi Therapeutics for Patients with Nano-rare Diseases
Published:
2022-01-18
(Crawled : 15:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-2.74%
|
O:
-2.0%
H:
0.0%
C:
0.0%
rare
technology
therapeutics
disease
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve a Functional Cure for Chronic Hepatitis B Virus (HBV) Infection at AASLD The Liver Meeting®
Published:
2021-11-12
(Crawled : 13:15)
- globenewswire.com
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-75.46%
|
O:
4.66%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-18.21%
|
O:
-2.06%
H:
0.0%
C:
0.0%
hepatitis
potential
biotech
technology
iot
liver
injection
infections
chronic hepatitis b
Alnylam Receives Positive Reimbursement Recommendation from the Canadian Agencies for Drugs and Technology in Health (CADTH) for use of GIVLAARI for the Treatment of Acute Hepatic Porphyria (AHP) in Adults
Published:
2021-10-18
(Crawled : 18:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-30.76%
|
O:
0.14%
H:
0.0%
C:
-2.37%
treatment
positive
drug
technology
hepatitis
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Presentation at AASLD’s The Liver Meeting® 2021
Published:
2021-10-15
(Crawled : 14:00)
- biospace.com/
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-80.24%
|
O:
-0.02%
H:
3.08%
C:
-2.81%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-31.0%
|
O:
0.34%
H:
0.09%
C:
-0.69%
presentation
hepatitis
biotech
technology
iot
liver
Vir Biotechnology Initiates Phase 2 Clinical Trial Evaluating the Combination of VIR-2218 and VIR-3434 as a Functional Cure Regimen for Chronic Hepatitis B Virus Infection
Published:
2021-07-15
(Crawled : 14:00)
- biospace.com/
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-77.56%
|
O:
0.08%
H:
2.71%
C:
2.31%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-15.22%
|
O:
-0.16%
H:
1.35%
C:
1.11%
phase 2
hepatitis
biotech
technology
iot
trial
injection
infections
chronic hepatitis b
Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021
Published:
2021-06-25
(Crawled : 13:00)
- globenewswire.com
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-83.97%
|
O:
-0.52%
H:
1.36%
C:
-7.74%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-0.63%
|
O:
-0.06%
H:
1.28%
C:
1.1%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-16.85%
|
O:
0.26%
H:
1.5%
C:
0.72%
hepatitis
ongoing
biotech
technology
iot
liver
trial
injection
infections
chronic hepatitis b
Immuneering Expands Board of Directors with Addition of Senior Biotechnology Executive Laurie Keating
Published:
2021-04-27
(Crawled : 19:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-22.16%
|
O:
-0.65%
H:
0.06%
C:
-0.24%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
1.06%
|
O:
-0.53%
H:
1.35%
C:
-0.59%
biotech
technology
iot
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
Published:
2021-04-21
(Crawled : 12:00)
- vbivaccines.com
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-83.59%
|
O:
-1.09%
H:
0.38%
C:
0.04%
VBIV
|
$0.6396
1.57%
1.55%
160K
|
Health Technology
|
-75.86%
|
O:
0.0%
H:
7.66%
C:
7.66%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
6.16%
|
O:
0.67%
H:
1.12%
C:
0.43%
treatment
phase 2
hepatitis
vbi-2601
biotech
vaccine
technology
iot
brii-835
trial
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.